project id: TCGA-COAD; case submitter id: TCGA-QG-A5Z1; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 71; days to birth: -26220; days to death: 256; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1940; age at diagnosis: 26220; ajcc pathologic m: MX; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 202.0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 516; days to sample procurement: 0; initial weight: 190.0; portion submitter id: TCGA-QG-A5Z1-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 99.0; percent tumor nuclei: 65.0;